Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rasmus, Mikiver"'
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Acral melanoma is a clinical subtype of melanoma with high mortality, on which research is limited in scope. This study aimed to assess incidence trends and melanoma-specific survival rates for acral melanoma in the Swedish population from 1990 to 20
Externí odkaz:
https://doaj.org/article/685a7046f4514b48a5d36f7500831cd6
Publikováno v:
EClinicalMedicine, Vol 65, Iss , Pp 102284- (2023)
Summary: Background: The incidence of melanoma in situ (MIS) is increasing even more rapidly than the incidence of cutaneous malignant melanoma (CMM). No previous studies have in detail investigated the survival in individuals diagnosed with MIS comp
Externí odkaz:
https://doaj.org/article/b04d7eef4505475ba535be151f5c2353
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Comprehensible, relevant information empowers patients, allowing them to take an active part in their care. We aim to investigate how Swedish melanoma patients perceive information provided in routine clinical practice and explore
Externí odkaz:
https://doaj.org/article/9d358134e96a4efba7ee8c23751e797c
Autor:
Hildur Helgadottir, Lars Ny, Gustav J Ullenhag, Johan Falkenius, Rasmus Mikiver, Roger Olofsson Bagge, Karolin Isaksson
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background Adjuvant treatments with PD-1 and BRAF+MEK inhibitors significantly prolong recurrence-free survival in stage III cutaneous melanoma. Yet, the effect on overall survival is still unclear. Based on recurrence-free survival outcomes, these t
Publikováno v:
Supportive Care in Cancer. 31
Purpose Few studies have focused on the late adverse events after oncologic treatment in pelvic cancer patients. Here, the treatment effect/interventions were studied on late side effects as GI, sexual, and urinary symptoms in pelvic cancer patients
Purpose Few studies have focused on the late adverse events after oncologic treatment in pelvic cancer patients. Here, the treatment effect/interventions were studied on late side effects as GI, sexual and urinary symptoms in pelvic cancer patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88a7098372b91cad53091ba7026dcbb0
https://doi.org/10.21203/rs.3.rs-2248214/v1
https://doi.org/10.21203/rs.3.rs-2248214/v1
Autor:
Karolin Isaksson, Lars Ny, Rasmus Mikiver, Ana Carneiro, Roger Olofsson Bagge, Dimitrios Katsarelias
Publikováno v:
Annals of Surgical Oncology
Background Cutaneous melanoma is steadily increasing worldwide. The new AJCC 8th edition was recently launched and introduced several changes in melanoma staging, particularly for stage III. We conducted a population-based registry study with the pur
Autor:
Kari Nielsen, Jan Lapins, Johan Lyth, Ismini Vassilaki, Rasmus Mikiver, Karolin Isaksson, Hanna Eriksson
Publikováno v:
Cancers
Volume 13
Issue 11
Cancers, Vol 13, Iss 2838, p 2838 (2021)
Volume 13
Issue 11
Cancers, Vol 13, Iss 2838, p 2838 (2021)
Background: The incidence of invasive cutaneous melanoma (CM) is increasing in Sweden. The aim was to present age- and sex-specific trends of the age-standardised incidence and the average annual percentage change (AAPC) for in situ and invasive CM.
Autor:
Jan Lapins, Rasmus Mikiver, Hanna Eriksson, Kari Nielsen, Christian Ingvar, Karolin Isaksson, Johan Lyth
Background The incidence of cutaneous malignant melanoma (CMM) continues to increase in most countries worldwide and the majority are diagnosed with thin tumours (Funding Agencies|M. Paulsson Fund; Gorthon Foundation; S. Paulsson Fund; LMK Foundation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d54552ee925426d320d247bf734d33da
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-165564
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-165564
Autor:
Dimitrios, Katsarelias, Hanna, Eriksson, Rasmus, Mikiver, Isabelle, Krakowski, Jonas A, Nilsson, Lars, Ny, Roger, Olofsson Bagge
Publikováno v:
Cancers
We thank De Giorgi et al for their interest in our study, and for raising important and relevant questions [...].